PhAST’s mission is to develop innovative diagnostic approaches to help solve the global challenge of antibiotic resistance.
We are passionate and committed to tackle one of today’s greatest threats to human health: antibiotic resistance. We are doing this by developing technology that significantly speeds up both the detection of bacterial pathogens in patient samples and the choice of the best antibiotic for treatment. Our technology leverages the power of single-cell imaging and microfluidic platforms to provide healthcare providers with the right diagnostic information at the right time. This will reduce usage of ineffective or excessive antibiotics, improve patient recovery through faster and more accurate diagnostics, and slow the spread of antibiotic resistance.
“On November 21, 2016, PhAST was awarded the Discovery Award from the Longitude Prize Committee . PhAST is excited to compete in the Longitude 10 million pound Prize for a diagnostic test that contributes to solve the global problem of antibiotic resistance”.
Our team includes world-leading experts in single-cell microbial imaging and microfluidic systems.
Lets get in touch. Send us a message!